片段(逻辑)
化学
表面等离子共振
药物发现
质谱法
化学型
立体化学
结晶学
色谱法
纳米技术
生物化学
计算机科学
纳米颗粒
材料科学
程序设计语言
精油
作者
Lucy A. Woods,Olan Dolezal,Bin Ren,John H. Ryan,Thomas S. Peat,Sally‐Ann Poulsen
标识
DOI:10.1021/acs.jmedchem.5b01940
摘要
Fragment-based drug discovery (FBDD) is contingent on the development of analytical methods to identify weak protein-fragment noncovalent interactions. Herein we have combined an underutilized fragment screening method, native state mass spectrometry, together with two proven and popular fragment screening methods, surface plasmon resonance and X-ray crystallography, in a fragment screening campaign against human carbonic anhydrase II (CA II). In an initial fragment screen against a 720-member fragment library (the "CSIRO Fragment Library") seven CA II binding fragments, including a selection of nonclassical CA II binding chemotypes, were identified. A further 70 compounds that comprised the initial hit chemotypes were subsequently sourced from the full CSIRO compound collection and screened. The fragment results were extremely well correlated across the three methods. Our findings demonstrate that there is a tremendous opportunity to apply native state mass spectrometry as a complementary fragment screening method to accelerate drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI